← Open Payments lookup

KRISTINA DADA: Open Payments

NPI 1487830097 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,293 in 111 payments from 21 companies in 2025. Trend: 2023 $1,262 · 2024 $2,950 · 2025 $2,293

Food & beverage: $2,293
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP23$643
Insmed, Inc.11$224
Merck Sharp & Dohme LLC6$186
GENZYME CORPORATION12$176
Grifols USA, LLC9$166
JAZZ PHARMACEUTICALS INC.8$153
Regeneron Healthcare Solutions, Inc.7$108
Boehringer Ingelheim Pharmaceuticals, Inc.5$99
GlaxoSmithKline, LLC.5$90
HARMONY BIOSCIENCES LLC3$66

Products named: FASENRA, DUPIXENT, Arikayce, Prolastin-C Liquid, WINREVAIR, XYWAV, NUCALA, WAKIX.

Industry payments across NE — which companies pay providers there.